Cristina Rizov
Research Subjects
Cristina Rizov has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Carolina Piterschi
Nicolae Testemitanu State University of Medicine and Pharmacy
2 shared publications - Lorina Vudu
Nicolae Testemitanu State University of Medicine and Pharmacy
2 shared publications Ana Cristal
1 shared publication- Aristia Seremet1 shared publication
- Dumitru Harea1 shared publication
Elena Băbălău
1 shared publication
Latest Publications
- 1 November 2025
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences"
- No. 2(82),p. 260-264
Prevalence of arrhythmias in patients with diabetes mellitus - evidence from current literature
Introduction: Diabetes mellitus is a chronic metabolic disorder with an increasing global prevalence, associated with a substantial burden of cardiovascular complications. Arrhythmias, particularly atrial fibrillation, are common manifestations in patients with diabetes, contributing to increased mortality and morbidity risk. Objective: To assess the prevalence and types of arrhythmias in patients with diabetes mellitus (DM) based on recent scientific literature. Methods: Narrative review of studies published between 2015-2025 (PubMed, Google Scholar, Hinari), including meta-analyses, population-based cohorts, and observational studies reporting arrhythmia prevalence in DM. Results: Atrial fibrillation is the most prevalent arrhythmia, with reported rates between 9-25% and a relative risk increase of 17-28% compared to the general population. Conduction disorders, bundle branch blocks, and prolonged QTc (≈13% of DM patients) are frequently observed and associated with an increased risk of malignant ventricular arrhythmias. Extended ECG monitoring reveals undiagnosed asymptomatic ("silent AF") cases. Conclusions: DM is associated with a significantly increased prevalence of arrhythmias, supporting active screening, periodic cardiac monitoring, and QTc. These data support active screening through extended ECG monitoring and periodic repolarization assessment in DM patients
- 1 November 2025
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences"
- No. 2(82),p. 260-264
Prevalence of arrhythmias in patients with diabetes mellitus - evidence from current literature
Introduction: Diabetes mellitus is a chronic metabolic disorder with an increasing global prevalence, associated with a substantial burden of cardiovascular complications. Arrhythmias, particularly atrial fibrillation, are common manifestations in patients with diabetes, contributing to increased mortality and morbidity risk. Objective: To assess the prevalence and types of arrhythmias in patients with diabetes mellitus (DM) based on recent scientific literature. Methods: Narrative review of studies published between 2015-2025 (PubMed, Google Scholar, Hinari), including meta-analyses, population-based cohorts, and observational studies reporting arrhythmia prevalence in DM. Results: Atrial fibrillation is the most prevalent arrhythmia, with reported rates between 9-25% and a relative risk increase of 17-28% compared to the general population. Conduction disorders, bundle branch blocks, and prolonged QTc (≈13% of DM patients) are frequently observed and associated with an increased risk of malignant ventricular arrhythmias. Extended ECG monitoring reveals undiagnosed asymptomatic ("silent AF") cases. Conclusions: DM is associated with a significantly increased prevalence of arrhythmias, supporting active screening, periodic cardiac monitoring, and QTc. These data support active screening through extended ECG monitoring and periodic repolarization assessment in DM patients
- Open Access
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 13-17
Manifestările clinice, complicațiile și tratamentul acromegaliei
Acromegaly is a rare neuroendocrine disease that requires a specific approach in the evaluation of clinical symptoms. Evaluation of medical records of 28 patients with acromegaly admitted to the „Endocrinology” department, IMSP Republican Clinical Hospital „Timofei Moșneaga” during the period 2018-2023 were analyzed. In men the mean age of acromegaly onset is 25.5 (± 5,86) years, in women is 46.29 (± 11,85) years. The most common early manifestations: facial changes, enlargement of the extremities and headache. The most frequent symptoms detected during the disease: headache (64.29%), visual disturbances (60.71%), facies acromegalis (57.14%), leg enlargement (53.57%), arthralgias (50%). The most common complications in patients were the following: cardiomyopathy (67.86%), hypertension (57.14%), thyroid gland disorders (42.86%), type 2 diabetes (35.71%). Out of 24 patients - 15 patients (62.5%) had recurrence of acromegaly. Acromegaly affects almost all body systems: endocrine, nervous, cardiovascular, musculoskeletal and others, leading to a wide variety of clinical symptoms. The most common symptoms detected during the disease were associated with local tumor effects, hormonal disturbances and changes in metabolism.
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 13-17
Open AccessManifestările clinice, complicațiile și tratamentul acromegaliei
Acromegaly is a rare neuroendocrine disease that requires a specific approach in the evaluation of clinical symptoms. Evaluation of medical records of 28 patients with acromegaly admitted to the „Endocrinology” department, IMSP Republican Clinical Hospital „Timofei Moșneaga” during the period 2018-2023 were analyzed. In men the mean age of acromegaly onset is 25.5 (± 5,86) years, in women is 46.29 (± 11,85) years. The most common early manifestations: facial changes, enlargement of the extremities and headache. The most frequent symptoms detected during the disease: headache (64.29%), visual disturbances (60.71%), facies acromegalis (57.14%), leg enlargement (53.57%), arthralgias (50%). The most common complications in patients were the following: cardiomyopathy (67.86%), hypertension (57.14%), thyroid gland disorders (42.86%), type 2 diabetes (35.71%). Out of 24 patients - 15 patients (62.5%) had recurrence of acromegaly. Acromegaly affects almost all body systems: endocrine, nervous, cardiovascular, musculoskeletal and others, leading to a wide variety of clinical symptoms. The most common symptoms detected during the disease were associated with local tumor effects, hormonal disturbances and changes in metabolism.
- Open Access
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 18-23
Managementul unui caz de hipotiroidism sever complicat cu efuziune pericardică masivă recidivantă în sindrom Down
Down’s syndrome is frequently associated with various endocrine dysfunctions, the most common being thyroid function disorders presented through a wide spectrum of manifestations, such as congenital and acquired hypothyroidism, especially the subclinical form, and less often hyperthyroidism. Symptoms of hypothyroidism are practically absent in subclinical forms, which requires regular screening for early detection of thyroid dysfunctions. We present of a clinical case from the Endocrinology Department of the „Timofei Moșneaga” Republican Clinical Hospital, successfully resolved following a multidisciplinary approach. The 25-year-old patient, diagnosed with Down syndrome since the age of 4, hospitalized in serious condition due to difficulty breathing, wet cough, dyspnea on moderate exertion, abdominal discomfort, acrocyanosis associated with hypotension and generalized edema. The presence of diffuse polyserositis was determined (hydropericardium with signs of cardiac tamponade, but without organic damage of the heart, bilateral pleurisy and minimal ascites), hormonal profile: TSH - 450 (0,17- 4,05 lU/ml), total T4- 30,2 (71,2-141 nmol/L). After performing two pericardiocentesis and active drainage of the pericardial cavity and initiating therapy with Levothyroxin 150 mcg and diuretics, she was discharged in a satisfactory condition with considerable changes in the hormones freeT4: 18 (12-22 pmol/l); TSH: 102 mlU/ml. This case illustrates the special challenges in establishing the correct diagnosis and therapeutic management of complications of severe hypothyroidism in patients with Down syndrome, such as myxedema and hydropericardium with cardiac tamponade. For this reason, increased vigilance in this category of patients and regular annual screening of thyroid dysfunctions will reduce the incidence of severe cases of thyroid pathology.
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 18-23
Open AccessManagementul unui caz de hipotiroidism sever complicat cu efuziune pericardică masivă recidivantă în sindrom Down
Down’s syndrome is frequently associated with various endocrine dysfunctions, the most common being thyroid function disorders presented through a wide spectrum of manifestations, such as congenital and acquired hypothyroidism, especially the subclinical form, and less often hyperthyroidism. Symptoms of hypothyroidism are practically absent in subclinical forms, which requires regular screening for early detection of thyroid dysfunctions. We present of a clinical case from the Endocrinology Department of the „Timofei Moșneaga” Republican Clinical Hospital, successfully resolved following a multidisciplinary approach. The 25-year-old patient, diagnosed with Down syndrome since the age of 4, hospitalized in serious condition due to difficulty breathing, wet cough, dyspnea on moderate exertion, abdominal discomfort, acrocyanosis associated with hypotension and generalized edema. The presence of diffuse polyserositis was determined (hydropericardium with signs of cardiac tamponade, but without organic damage of the heart, bilateral pleurisy and minimal ascites), hormonal profile: TSH - 450 (0,17- 4,05 lU/ml), total T4- 30,2 (71,2-141 nmol/L). After performing two pericardiocentesis and active drainage of the pericardial cavity and initiating therapy with Levothyroxin 150 mcg and diuretics, she was discharged in a satisfactory condition with considerable changes in the hormones freeT4: 18 (12-22 pmol/l); TSH: 102 mlU/ml. This case illustrates the special challenges in establishing the correct diagnosis and therapeutic management of complications of severe hypothyroidism in patients with Down syndrome, such as myxedema and hydropericardium with cardiac tamponade. For this reason, increased vigilance in this category of patients and regular annual screening of thyroid dysfunctions will reduce the incidence of severe cases of thyroid pathology.
- Open Access
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 46-50
Evaluarea riscului cardiometabolic la femeile de vârstă fertilă cu obezitate. date preliminare
Obesity is a chronic disease with extensive health consequences. Its prevalence is constantly increasing, including among children and young people. In this study we assessed the cardiometabolic risk and its correlation with leptin/adiponectin ratio in obese young women. We enrolled 72 apparently healthy women, comprising 36 with normal weight (BMI ≤ 25 kg/m²) and 36 with obesity (BMI ≥ 30 kg/m²). The mean age was 34.1±5.6 years. Clinical and paraclinical parameters were studied: body mass index (BMI), waist and hip circumference, waist-hip ratio, blood presure, serum level of glucose, insulin, leptin, adiponectin, total cholesterol, HDL cholesterol, LDL cholesterol. Compared to normal weight women, obese women have had significantly higher levels of leptin, insulin and blood glucose (p < 0.001). But the level of adiponectin was lower (p < 0.001). The leptin/adiponectin ratio had a positive correlation with BMI, waist circumferince, waist-hip ratio, blood glucose, insulinemia, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), LDL cholesterol and negative correlation with HDL cholesterol in the group of obese women. Research results revealed higher cardiometabolic risk in young women with obesity. The leptin/adiponectin ratio is in direct correlation with this risk, being a good predictor of insulin resistance.
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 46-50
Open AccessEvaluarea riscului cardiometabolic la femeile de vârstă fertilă cu obezitate. date preliminare
Obesity is a chronic disease with extensive health consequences. Its prevalence is constantly increasing, including among children and young people. In this study we assessed the cardiometabolic risk and its correlation with leptin/adiponectin ratio in obese young women. We enrolled 72 apparently healthy women, comprising 36 with normal weight (BMI ≤ 25 kg/m²) and 36 with obesity (BMI ≥ 30 kg/m²). The mean age was 34.1±5.6 years. Clinical and paraclinical parameters were studied: body mass index (BMI), waist and hip circumference, waist-hip ratio, blood presure, serum level of glucose, insulin, leptin, adiponectin, total cholesterol, HDL cholesterol, LDL cholesterol. Compared to normal weight women, obese women have had significantly higher levels of leptin, insulin and blood glucose (p < 0.001). But the level of adiponectin was lower (p < 0.001). The leptin/adiponectin ratio had a positive correlation with BMI, waist circumferince, waist-hip ratio, blood glucose, insulinemia, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), LDL cholesterol and negative correlation with HDL cholesterol in the group of obese women. Research results revealed higher cardiometabolic risk in young women with obesity. The leptin/adiponectin ratio is in direct correlation with this risk, being a good predictor of insulin resistance.
- Open Access
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 5-12
Adenom hipofizar izolat familial. Caz clinic
Familial isolated pituitary adenoma (FIPA) is a term used to identify a genetic condition with pituitary tumors without other endocrine abnormalities or other associated abnormalities. FIPA is a heterogeneous disease both clinically and genetically. Their clinical picture includes signs and symptoms of different types of pituitary adenoma, either homogeneous (all affected family members have the same type of adenoma) or heterogeneous (different types of adenoma within the same family). A 57-year-old patient presented in January 2024 with the following complaints: headache, sleep disturbances, arthralgias, ossalgias, and myalgias. In 2014, she was diagnosed with a non-secreting pituitary macroadenoma, being reevaluated annually, and in dynamics without significant changes. Aggravated eredocollateral anamnesis - the 61-yearold sister, was diagnosed with Pituitary Macroadenoma (10.6 x 12.9 x 14.9 mm) secreting STH (Acromegaly) in 2021. Also taking into account the presence of the clinical picture specific to FIPA it is assumed that both the brother and the daughter are suspects for Familial Pituitary Adenoma, but due to the lack of clinical and imaging investigations, the diagnosis was not confirmed. Genetic evaluation of the aryl hydrocarbon receptor-interacting protein (AIP) gene will allow confirmation of the AIP gene mutation that is warranted in patients with isolated familial pituitary adenoma. Early screening and dynamic re-evaluation can prevent complications, since most of the time FIPA can be silent for clinical and hormonal.
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 5-12
Open AccessAdenom hipofizar izolat familial. Caz clinic
Familial isolated pituitary adenoma (FIPA) is a term used to identify a genetic condition with pituitary tumors without other endocrine abnormalities or other associated abnormalities. FIPA is a heterogeneous disease both clinically and genetically. Their clinical picture includes signs and symptoms of different types of pituitary adenoma, either homogeneous (all affected family members have the same type of adenoma) or heterogeneous (different types of adenoma within the same family). A 57-year-old patient presented in January 2024 with the following complaints: headache, sleep disturbances, arthralgias, ossalgias, and myalgias. In 2014, she was diagnosed with a non-secreting pituitary macroadenoma, being reevaluated annually, and in dynamics without significant changes. Aggravated eredocollateral anamnesis - the 61-yearold sister, was diagnosed with Pituitary Macroadenoma (10.6 x 12.9 x 14.9 mm) secreting STH (Acromegaly) in 2021. Also taking into account the presence of the clinical picture specific to FIPA it is assumed that both the brother and the daughter are suspects for Familial Pituitary Adenoma, but due to the lack of clinical and imaging investigations, the diagnosis was not confirmed. Genetic evaluation of the aryl hydrocarbon receptor-interacting protein (AIP) gene will allow confirmation of the AIP gene mutation that is warranted in patients with isolated familial pituitary adenoma. Early screening and dynamic re-evaluation can prevent complications, since most of the time FIPA can be silent for clinical and hormonal.